Kolomeyer Natasha N

Special Commentary: Reporting Clinical Endpoints in Studies of Minimally Invasive Glaucoma Surgery.

The suggested MCID for the cumulative probability of success for MIGS combined with CE-IOL at 2 years is 65%.

Lessons Learned From 2 Large Community-based Glaucoma Screening Studies.

This editorial highlights lessons learned from 2 large prospective trials: the Philadelphia Telemedicine Glaucoma Detection and Follow-up Study and the Screening To Prevent Glaucoma Study.

XEN Gel Stent to Treat ICE Syndrome: 4 Cases.

XEN is a safe and effective option for surgical management of ICE syndrome-related glaucoma. Further follow-up surveillance is necessary.

Utility of the Modified Isolated-check Visual Evoked Potential Technique in Functional Glaucoma Assessment.

icVEP technology has the potential to complement standard achromatic perimetry in functional assessment of glaucomatous defects.

Short-Term Outcomes of Bimatoprost Sustained-Release Intracameral Implant in Glaucoma.

Intracameral Bimatoprost SR reduced IOP and decreased the number of medications. Prior history of SLT did not impact Bimatoprost SR treatment outcomes.

American Glaucoma Society Position Paper: Information Sharing Using Established Standards Is Essential to the Future of Glaucoma Care.

Utility of Optical Coherence Tomography (OCT) in Centers For Medicare and Medicaid Services (CMS)-defined Severe Glaucoma Patients.

Our data demonstrate a substantial portion of eyes with CMS-defined severe glaucoma have measurable RNFL above the floor in at least 1 vertical quadrant that may be longitudinally monitored for progression.

Utility of the Modified Isolated-check Visual Evoked Potential Technique in Functional Glaucoma Assessment.